computer-based eye-tracking analysis Search Results


90
King Devick Technologies Inc computer-based eye-tracking analysis
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Computer Based Eye Tracking Analysis, supplied by King Devick Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer-based eye-tracking analysis/product/King Devick Technologies Inc
Average 90 stars, based on 1 article reviews
computer-based eye-tracking analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
King Devick Technologies Inc king-devick test
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
King Devick Test, supplied by King Devick Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/king-devick test/product/King Devick Technologies Inc
Average 90 stars, based on 1 article reviews
king-devick test - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MathWorks Inc matlab software
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Matlab Software, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matlab software/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
matlab software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Tobii AB tobii pro lab software
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Tobii Pro Lab Software, supplied by Tobii AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tobii pro lab software/product/Tobii AB
Average 90 stars, based on 1 article reviews
tobii pro lab software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Affectiva Inc facial expression analyses affdex algorithm
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Facial Expression Analyses Affdex Algorithm, supplied by Affectiva Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/facial expression analyses affdex algorithm/product/Affectiva Inc
Average 90 stars, based on 1 article reviews
facial expression analyses affdex algorithm - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BIOPAC galvanic skin response biopac mp160
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Galvanic Skin Response Biopac Mp160, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/galvanic skin response biopac mp160/product/BIOPAC
Average 90 stars, based on 1 article reviews
galvanic skin response biopac mp160 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
EyeTracking Inc smi software begaze version 3.3.56
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Smi Software Begaze Version 3.3.56, supplied by EyeTracking Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smi software begaze version 3.3.56/product/EyeTracking Inc
Average 90 stars, based on 1 article reviews
smi software begaze version 3.3.56 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Tobii AB video-oculograph tobii pro fusion
Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
Video Oculograph Tobii Pro Fusion, supplied by Tobii AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/video-oculograph tobii pro fusion/product/Tobii AB
Average 90 stars, based on 1 article reviews
video-oculograph tobii pro fusion - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Illumina Inc 16s rrna sequencing
Overview of methodological characteristics.
16s Rrna Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/16s rrna sequencing/product/Illumina Inc
Average 90 stars, based on 1 article reviews
16s rrna sequencing - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Logitech Inc logitech g27 controller
Overview of methodological characteristics.
Logitech G27 Controller, supplied by Logitech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/logitech g27 controller/product/Logitech Inc
Average 90 stars, based on 1 article reviews
logitech g27 controller - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.

Journal: Journal of Alzheimer's Disease

Article Title: Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

doi: 10.3233/JAD-215551

Figure Lengend Snippet: Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.

Article Snippet: To examine whether computer-based eye-tracking (ET) analysis of King-Devick (KD) test results differentiates cognitively healthy persons from persons with minor problems in cognitive testing or diagnosed mild AD.

Techniques: Control, Battery

King-Devick (KD) reading test scores and related  eye-tracking  (ET) recordings

Journal: Journal of Alzheimer's Disease

Article Title: Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

doi: 10.3233/JAD-215551

Figure Lengend Snippet: King-Devick (KD) reading test scores and related eye-tracking (ET) recordings

Article Snippet: To examine whether computer-based eye-tracking (ET) analysis of King-Devick (KD) test results differentiates cognitively healthy persons from persons with minor problems in cognitive testing or diagnosed mild AD.

Techniques:

Overview of methodological characteristics.

Journal: Molecular Psychiatry

Article Title: A systematic review exploring the association between the human gut microbiota and brain connectivity in health and disease

doi: 10.1038/s41380-023-02146-4

Figure Lengend Snippet: Overview of methodological characteristics.

Article Snippet: , [ – ] , Cai (2021)(a)/Zhu (2022)(b)/Zheng (2022) (c) (three publications based on the same study) , Collection: fresh Sequencing type: 16s rRNA sequencing Sequencing technology: Illumina Hiseq Region: V4 Pipeline: UPARSE/USEARCH (v9.1.13) Database: RDP classifier (v2.2) with GreenGenes (v201305) as training database Clustering: OTU Rarified: no Filtering: no Transformation: NA , Richness (a,b): Sobs, Ace, Chao Diversity: Shannon, Simpson , , Bacteroides -, Prevotella - and Ruminococcus -high clusters, based on Jensen-Shannon distance and PAM , rs-fMRI Eyes closed DTI (b,c) , (a): Anterior/ posterior DMN, ECN, left/right FPN, SN, DAN, VAN, dorsal/ventral SMN, AN, lateral/posterior VN, based on ICA (b) Data-driven selection based on outcomes multi-set canonical association analysis plus joint ICA (c) No a priori ROI selection , (a) Internetwork: network-to-network Fisher’s z-transformed correlations Intranetwork: contribution of the time course to each voxel comprising an independent component (b) Mixing coefficients from multiset canonical association analysis plus joint ICA, with as input: > FC: FCD computed as number of voxel-to-voxel correlations of a particular voxel to all other voxels with r > 0.25, normalized by the global mean FCD > SC: voxelwise FA > Other: Regional homogeneity, cerebral blood flow, gray matter volume (c): SC computed as the number of fibers between each set of ROIs based on fiber tracking algorithm. FC computed as Fisher z-transformed correction between all ROIs, resulting in two 90×90 matrices > For SC and FC: computation of network topological metrics from ROI matrices as measure of connectivity ((normalized) clustering coefficient, (normalized) characteristic path length, small-worldness property, nodal degree centrality, nodal efficiency, nodal betweenness > SC-FC coupling: Pearson correlation between SC and FC ROI matrices , > Partial correlations (alpha diversity) and ANOVA (clusters) to test the association with network connectivity/FCD/FA > For significant associations: mediation analysis between alpha diversity/clusters and cognition, with connectivity as mediator Covariates: frame-wise displacement (a,c), age and sex Multiple testing correction: FDR, cluster-level FWE (b,c) or Bonferroni (c) , > Letter 3-back task to assess working memory > Digit span task to assess attention > Go/No-Go task to assess response inhibition.

Techniques: Selection, Sequencing, Transformation Assay, Inhibition, Preserving, Functional Assay, Control, Activity Assay, Diffusion-based Assay